Simon-Sanchez Javier, Hanson Melissa, Singleton Amanda, Hernandez Dena, McInerney Aideen, Nussbaum Robert, Werner John, Gallardo Marisol, Weiser Roberto, Gwinn-Hardy Katrina, Singleton Andrew B, Clarimon Jordi
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Building 35 Room 1A100, MSC 3707, 35 Lincoln Drive, Bethesda, MD 20892, USA.
Neurosci Lett. 2005;382(1-2):191-4. doi: 10.1016/j.neulet.2005.03.015. Epub 2005 Apr 1.
The spinocerebellar ataxias (SCAs) are progressive neurodegenerative disorders linked to more than 20 genetic loci. Most often, these diseases are caused by expansion of triplet repeats encoding polyglutamine (polyQ) tracts. The phenotype is variable and can cause a disease that overlaps clinically with Parkinson's disease (PD). l-Dopa-responsive parkinsonism with minimal cerebellar deficits has been described in SCA2 and SCA3. In order to define if mutation at these loci is a common cause of clinically defined parkinsonism we typed the SCA-2 and SCA-3 repeats for expansion in a series of 280 patients diagnosed with PD or parkinsonism. We identified one pathogenic expansion in SCA-2 in a North American family with autosomal dominant parkinsonism.
脊髓小脑共济失调(SCAs)是与20多个基因位点相关的进行性神经退行性疾病。这些疾病最常见的病因是编码聚谷氨酰胺(polyQ)序列的三联体重复序列扩增。其表型具有多样性,可导致一种在临床上与帕金森病(PD)重叠的疾病。SCA2和SCA3中曾描述过具有轻微小脑功能缺陷的左旋多巴反应性帕金森综合征。为了确定这些位点的突变是否是临床定义的帕金森综合征的常见病因,我们对280例诊断为PD或帕金森综合征的患者进行了SCA - 2和SCA - 3重复序列扩增检测。我们在一个患有常染色体显性帕金森综合征的北美家族中发现了1例SCA - 2的致病性扩增。